| |
Company
Roster
|
|
Total
Insiders : |
43 |
|
|
|
Total
Direct Shares :
|
4,918,074 |
|
|
Total
Indirect Shares :
|
38,117,809 |
| |
%
Held by Insiders:
|
24.07% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Shanmugam Muthusamy |
HEAD OF R&D, COO-NOVITIUM OPS, Director |
2024-04-19 |
68,652 |
2024-04-19 |
787,620 |
| Cook Meredith |
SR. VP, GENERAL COUNSEL & SEC. |
2024-04-12 |
59,731 |
2022-07-18 |
0 |
| Carey Stephen P. |
SVP & CFO |
2024-04-10 |
166,968 |
2017-03-31 |
0 |
| Marken James G. |
SVP OPS & PROD DEV |
2024-04-10 |
116,006 |
2013-06-19 |
0 |
| Gassert Chad |
SVP - CORP. DEV. & STRATEGY |
2024-04-01 |
49,679 |
2024-04-01 |
253,226 |
| Rowland Thomas Andrew |
Officer |
2024-03-28 |
34,036 |
|
0 |
| Lalwani Nikhil |
PRESIDENT & CEO, Director |
2024-03-23 |
394,174 |
2020-09-08 |
0 |
| Gutwerg Ori |
SVP, GENERICS |
2024-03-07 |
80,212 |
2021-02-15 |
0 |
| Mutz Christopher |
HEAD OF RARE DISEASE |
2024-03-07 |
85,277 |
2021-02-15 |
0 |
| Pera Antonio R |
Director |
2024-03-04 |
26,627 |
2020-08-05 |
0 |
| Davis Krista |
SVP, CHIEF HR OFFICER |
2024-02-29 |
51,545 |
2022-09-12 |
0 |
| Leonard Matthew J |
Director |
2023-08-21 |
7,583 |
2023-08-21 |
0 |
| Brown Robert E. Jr |
10% Owner |
2023-08-16 |
1,819,259 |
2013-11-01 |
0 |
| Tannenbaum Renee P |
Director |
2023-05-23 |
20,211 |
2022-03-19 |
0 |
| Haughey Thomas |
Director |
2023-05-23 |
47,116 |
2018-06-06 |
0 |
| Walsh Patrick D |
Director |
2023-05-23 |
70,302 |
2018-06-06 |
0 |
| Thoma Jeanne |
Director |
2023-05-23 |
36,199 |
2020-08-05 |
0 |
| Nash David |
Director |
2023-05-23 |
38,561 |
2018-06-06 |
0 |
| Schrepfer Robert W |
|
2021-03-29 |
87,477 |
2014-05-22 |
0 |
| Przybyl Arthur |
President and CEO, Director |
2020-04-07 |
190,309 |
2013-06-19 |
0 |
| Penn Thomas A. |
Director |
2019-03-28 |
14,301 |
2013-06-19 |
16,918,469 |
| Holubow Fred |
Director |
2018-03-20 |
14,811 |
2004-05-10 |
210,000 |
| Marshbanks Tracy |
Director |
2017-03-31 |
11,110 |
2018-05-16 |
349,934 |
| Raynor Daniel |
Director |
2017-03-31 |
11,110 |
2018-03-19 |
289,003 |
| Arnold Charlotte C. |
Vice President and CFO |
2016-04-07 |
54,298 |
2013-06-19 |
0 |
| Lankau Peter A |
Director |
2016-04-07 |
2,500 |
2015-10-12 |
0 |
| Mangano Ross J |
Director |
2014-09-15 |
26,914 |
2013-08-20 |
70,340 |
| Jamnick Robert J. |
VP, Quality & Product Develop. |
2014-05-22 |
48,118 |
2013-06-19 |
0 |
| Meridian Venture Partners Ii, Co. |
10% Owner |
2013-06-19 |
0 |
2013-06-19 |
16,918,469 |
| Rosenow Edward C III |
Director |
2011-11-14 |
20,540 |
2003-07-17 |
0 |
| Sullivan Louis |
Director |
2011-08-15 |
47,898 |
2003-07-17 |
0 |
| Donenberg Philip B |
Sr. VP of Finance, CFO & Secy |
2011-08-08 |
44,322 |
2003-08-04 |
0 |
| Potts John T Jr |
Director |
2009-10-14 |
5,581 |
2009-10-14 |
0 |
| Sherwin Stephen A |
Director |
2009-10-14 |
86,760 |
2009-10-14 |
0 |
| Kjaer Peter |
Director |
2008-01-08 |
34,425 |
2003-07-17 |
0 |
| Morgenstern Victor A |
Director |
2006-12-20 |
455,571 |
2006-12-20 |
133,281 |
| Simes Stephen M |
Vice Chairman, President & CEO, Director |
2006-03-27 |
66,879 |
2011-01-18 |
202,267 |
| Bell Steven J |
VP Research & Pre-Clinical Dev |
2005-04-21 |
875 |
2004-10-08 |
0 |
| Lehman Leah M |
Vice President, Prod. Dev. |
2005-04-19 |
0 |
2003-08-04 |
0 |
| Perceptive Advisors Llc |
10% Owner |
2004-12-03 |
225,000 |
2004-12-03 |
209,100 |
| Cho Michael |
Member of Sec. 13(d) 10% group |
2004-08-16 |
225,000 |
2004-08-16 |
1,776,100 |
| Ho Angela |
Director |
2004-03-18 |
72,137 |
2003-09-10 |
0 |
| Snabes Michael C |
|
|
0 |
|
0 |
|
0.52 (0.79%) 
